WebCTAT methods . Tables for a “Complete, Transparent, Accurate and Timely account” (CTAT) are now mandatory for all revised submissions. The aim is to enhance the … Web• Refer to the CTAT in the main text as ‘Supplementary CTAT Table’ • Do not add subheadings • Add as many rows as needed to include all information • Only include one item per row . If the CTAT form is not relevant to your study, please outline the reasons why: 1.1 Antibodies Name Citation Supplier Cat no. Clone no. Anti-FXR
Journal of Hepatology CTAT methods - ResearchGate
Webplease refer to the CTAT table and supplementary information. Results Silencing hepatocyte TAZ in pre-tumor NASH mice suppresses HCC tumor development We began our investigation with a well-characterized and vali-dated NASH model that uses a diet rich in fructose, palmitate, and cholesterol.8 ,14 22–24 In this model, early fibrosis occurs ... WebRefer to the CTAT in the main text as ‘Supplementary CTAT Table’ Do not add subheadings Add as many rows as needed to include all information Only include one item per row If the CTAT form is not relevant to your study, please outline the reasons why: 1.1 Antibodies Name Citation Supplier Cat no. Clone no. high back and legs converable sofa
Elsevier An Information Analytics Business
WebApr 14, 2024 · IntroductionMesenchymal stromal cells (MSC) therapy has emerged as a potential treatment option for refractory FCGS. However, there is a lack of long-term data on the use of MSC therapy in cats. This study aimed to evaluate the long-term safety and efficacy of MSC therapy for FCGS and investigate potential factors associated with … WebCTAT methods Tables for a “Complete, Transparent, Accurate and Timely account” (CTAT) are now mandatory for all revised submissions. The aim is to enhance the reproducibility … WebDec 13, 2024 · For further details regarding the materials and methods used, please refer to the CTAT table and supplementary information. ... Reagents and resources are included in the Methods or Supplementary Materials. Conflict of interest. NorthSea Therapeutics BV acquired the commercial rights for icosabutate. DS and JK are paid consultants and have ... high back armchair next